PhaseWell Research Acquires Chase Medical Research
March 19, 2026
PhaseWell Research, a multisite clinical research company headquartered in Nashville, Tennessee, announced it has acquired Chase Medical Research, a Connecticut-based clinical research site with locations in Waterbury and Hamden. The acquisition strengthens PhaseWell’s presence in the Northeast and expands its ability to support cardiometabolic and central nervous system clinical research in community-based settings.
- Buyers
- PhaseWell Research
- Targets
- Chase Medical Research
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
Healthcare Services
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
-
Flourish Research (NMS Capital-backed) Acquires Valley Clinical Trials
September 15, 2023
Healthcare Services
NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.
-
Headlands Research Acquires Pharmasite Research
February 29, 2024
Healthcare Services
Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
-
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022
Healthcare Services
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
CRH Medical (WELL Health) Acquires Majority Stakes in Two Anesthesia Practices
May 27, 2021
Healthcare Services
CRH Medical Corporation, a wholly owned subsidiary of WELL Health Technologies, acquired 51% stakes in Northern Indiana Anesthesia Associates, LLC and an add-on Bradenton, Florida practice for FDHS Anesthesia, LLC. The two accretive add-ons have a combined annualized revenue run-rate of approximately US$3.3 million, add 16 practitioners, and expand CRH's anesthesia footprint across ambulatory surgical centers in the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.